Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,843
archived clinical trials in
Prostate Cancer

Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Grady Memorial Hospital
22
mi
from 43215
Delaware, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Grady Memorial Hospital
22
mi
from 43215
Delaware, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Blanchard Valley Medical Associates
80
mi
from 43215
Findlay, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Blanchard Valley Medical Associates
80
mi
from 43215
Findlay, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fremont Memorial Hospital
95
mi
from 43215
Fremont, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fremont Memorial Hospital
95
mi
from 43215
Fremont, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Kenton Oncology, Incorporated
56
mi
from 43215
Kenton, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Kenton Oncology, Incorporated
56
mi
from 43215
Kenton, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fairfield Medical Center
27
mi
from 43215
Lancaster, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fairfield Medical Center
27
mi
from 43215
Lancaster, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Lima Memorial Hospital
76
mi
from 43215
Lima, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Lima Memorial Hospital
76
mi
from 43215
Lima, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Strecker Cancer Center at Marietta Memorial Hospital
91
mi
from 43215
Marietta, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Strecker Cancer Center at Marietta Memorial Hospital
91
mi
from 43215
Marietta, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Northwest Ohio Oncology Center
116
mi
from 43215
Maumee, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Northwest Ohio Oncology Center
116
mi
from 43215
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Luke's Hospital
116
mi
from 43215
Maumee, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Luke's Hospital
116
mi
from 43215
Maumee, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Licking Memorial Cancer Care Program at Licking Memorial Hospital
33
mi
from 43215
Newark, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Licking Memorial Cancer Care Program at Licking Memorial Hospital
33
mi
from 43215
Newark, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Charles Mercy Hospital
118
mi
from 43215
Oregon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Charles Mercy Hospital
118
mi
from 43215
Oregon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Clinic - Oregon
118
mi
from 43215
Oregon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Clinic - Oregon
118
mi
from 43215
Oregon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Firelands Regional Medical Center
103
mi
from 43215
Sandusky, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
North Coast Cancer Care, Incorporated
103
mi
from 43215
Sandusky, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
North Coast Cancer Care, Incorporated
103
mi
from 43215
Sandusky, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mercy Medical Center
43
mi
from 43215
Springfield, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mercy Medical Center
43
mi
from 43215
Springfield, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Community Hospital of Springfield and Clark County
40
mi
from 43215
Springfield, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Community Hospital of Springfield and Clark County
40
mi
from 43215
Springfield, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Flower Hospital Cancer Center
125
mi
from 43215
Sylvania, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Flower Hospital Cancer Center
125
mi
from 43215
Sylvania, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mercy Hospital of Tiffin
80
mi
from 43215
Tiffin, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mercy Hospital of Tiffin
80
mi
from 43215
Tiffin, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Hospital
121
mi
from 43215
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Hospital
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
St. Vincent Mercy Medical Center
121
mi
from 43215
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
St. Vincent Mercy Medical Center
121
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Medical University of Ohio Cancer Center
117
mi
from 43215
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Medical University of Ohio Cancer Center
117
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
CCOP - Toledo Community Hospital
120
mi
from 43215
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
CCOP - Toledo Community Hospital
120
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Toledo Clinic, Incorporated - Main Clinic
124
mi
from 43215
Toledo, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Toledo Clinic, Incorporated - Main Clinic
124
mi
from 43215
Toledo, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Fulton County Health Center
125
mi
from 43215
Wauseon, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Fulton County Health Center
125
mi
from 43215
Wauseon, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital
6043
mi
from 43215
Westerville, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Mount Carmel Cancer Services at Mount Carmel St. Ann's Hospital
6043
mi
from 43215
Westerville, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Genesis - Good Samaritan Hospital
53
mi
from 43215
Zanesville, OH
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Genesis - Good Samaritan Hospital
53
mi
from 43215
Zanesville, OH
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Allegheny Cancer Center at Allegheny General Hospital
162
mi
from 43215
Pittsburgh, PA
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Allegheny Cancer Center at Allegheny General Hospital
162
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
AnMedical Health Cancer Center
376
mi
from 43215
Anderson, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
AnMedical Health Cancer Center
376
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
CCOP - Upstate Carolina
351
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Gibbs Regional Cancer Center at Spartanburg Regional Medical Center
349
mi
from 43215
Spartanburg, SC
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Rapid City Regional Hospital
1071
mi
from 43215
Rapid City, SD
Click here to add this to my saved trials
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated:  6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
1261
mi
from 43215
Sheridan, WY
Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men
Status: Enrolling
Updated: 6/27/2016
Welch Cancer Center at Sheridan Memorial Hospital
1261
mi
from 43215
Sheridan, WY
Click here to add this to my saved trials
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
A Pilot Study to Test the Feasibility and Immunologic Impact of Sipuleucel-T (Provenge) Administered With or Without Anti-PD-1 mAb (CT-011) and Low Dose Cyclophosphamide in Men With Advanced Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated:  6/28/2016
Augusta University
451
mi
from 43215
Augusta, GA
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancer
A Pilot Study to Test the Feasibility and Immunologic Impact of Sipuleucel-T (Provenge) Administered With or Without Anti-PD-1 mAb (CT-011) and Low Dose Cyclophosphamide in Men With Advanced Castrate-Resistant Prostate Cancer
Status: Enrolling
Updated: 6/28/2016
Augusta University
451
mi
from 43215
Augusta, GA
Click here to add this to my saved trials
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated:  6/28/2016
Methodist Hospital
166
mi
from 43215
Indianapolis, IN
Registry and Database Lap Prostatectomy
Laparoscopic Radical Prostatectomy: A Registry and Database
Status: Enrolling
Updated: 6/28/2016
Methodist Hospital
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Northeast Alabama Regional Medical Center
462
mi
from 43215
Anniston, AL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Northeast Alabama Regional Medical Center
462
mi
from 43215
Anniston, AL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Rebecca and John Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Rebecca and John Moores UCSD Cancer Center
1950
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Cedars-Sinai Comprehensive Cancer Center at Cedars-Sinai Medical Center
1972
mi
from 43215
Los Angeles, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Diego
1950
mi
from 43215
San Diego, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Diego
1950
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
UCSF Comprehensive Cancer Center
2108
mi
from 43215
San Francisco, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
UCSF Comprehensive Cancer Center
2108
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - San Francisco
2111
mi
from 43215
San Francisco, CA
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - San Francisco
2111
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
CCOP - Christiana Care Health Services
388
mi
from 43215
Newark, DE
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
CCOP - Christiana Care Health Services
388
mi
from 43215
Newark, DE
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
325
mi
from 43215
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Lombardi Cancer Center at Georgetown University Medical Center
325
mi
from 43215
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Walter Reed Army Medical Center
328
mi
from 43215
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Walter Reed Army Medical Center
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Veterans Affairs Medical Center - Washington, DC
328
mi
from 43215
Washington,
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Veterans Affairs Medical Center - Washington, DC
328
mi
from 43215
Washington,
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Broward General Medical Center
972
mi
from 43215
Fort Lauderdale, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Broward General Medical Center
972
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Memorial Regional Hospital Comprehensive Cancer Center
977
mi
from 43215
Hollywood, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Memorial Regional Hospital Comprehensive Cancer Center
977
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Mount Sinai Medical Center CCOP
991
mi
from 43215
Miami Beach, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Mount Sinai Medical Center CCOP
991
mi
from 43215
Miami Beach, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Florida Hospital Cancer Institute
792
mi
from 43215
Orlando, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Florida Hospital Cancer Institute
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
Palm Beach Cancer Institute, LLC
931
mi
from 43215
West Palm Beach, FL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
Palm Beach Cancer Institute, LLC
931
mi
from 43215
West Palm Beach, FL
Click here to add this to my saved trials
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  6/30/2016
MBCCOP - University of Illinois at Chicago
277
mi
from 43215
Chicago, IL
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study Of Estramustine, Docetaxel, And Exisulind (IND #64733) In Men With Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 6/30/2016
MBCCOP - University of Illinois at Chicago
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials